Replies to post #51675 on Intellicell Biosciences Inc (fka SVFC)

[BigBadWolf]

SVFC NO DILUTION GUARANTEE


In accordance with the foregoing, we will mail the Notice of Stockholder Action by Written Consent on or about February 9, 2014.

We intend to file the Amendment with the Secretary of State of the State of Nevada promptly after the twentieth (20 th ) day following the date on which this Information Statement is mailed to the Stockholders.


http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9731574



20 days from February 9th is March 1st, so until then A/S is 1.5B and the OS is virtually maxed out, so basically there is a NO DILUTION GUARANTEE. And by the looks of it, the company has just started its PR cycle to use that month to get the PPS back to its fair value. The CEO even mentioned the stock performance on his Twitter for the first time!

[cazual]

SVFC $$$$ On watch for granting of International Patent! Getting closer...and closer...check it out!
European Patent basics: http://epo.org/applying/basics.html

5. Publication of the application***DONE!!!!!!!*****see link below

The application is published - normally together with the search report - 18 months after the date of filing or, if priority was claimed, the priority date. Applicants then have six months to decide whether or not to pursue their application by requesting substantive examination. Alternatively, an applicant who has requested examination already will be invited to confirm whether the application should proceed. Within the same time limit the applicant must pay the appropriate designation fee and, if applicable, the extension fees. From the date of publication, a European patent application confers provisional protection on the invention in the states designated in the application. However, depending on the relevant national law, it may be necessary to file a translation of the claims with the patent office in question and have this translation published.

6. Substantive examination****DONE!!!!!!!*****see link below

After the request for examination has been made, the European Patent Office examines whether the European patent application and the invention meet the requirements of the European Patent Convention and whether a patent can be granted. An examining division normally consists of three examiners, one of whom maintains contact with the applicant or representative. The decision on the application is taken by the examining division as a whole in order to ensure maximum objectivity.


****European Patent Register, Event History: EP2658969: https://register.epo.org/application?number=EP11854049&lng=en&tab=event

**** 04.10.2013 (US date 10/04/2013) Publication in section I.1 EP Bulletin****DONE!!!!!!*****
**** 09.10.2013 (US date 10/09/3013) Notification on forthcoming publication of bibliographic data****DONE!!!!!!!!*******

****04.10.2013 Request for examination filed****DONE!!!!!!********

Guess which step is next?.....See below!!!!!!!!!Hint..Step #7!!!!!!!!!!!!!


****** 7. THE GRANT OF A PATENT!!!!!! ********

If the examining division decides that a patent can be granted, it issues a decision to that effect. A mention of the grant is published in the European Patent Bulletin once the translations of the claims have been filed and the fee for grant and publication have been paid. The decision to grant takes effect on the date of publication. The granted European patent is a "bundle" of individual national patents.

European Patent in National Phase
https://register.epo.org/application?number=EP11854049&Ing=en&tab=main

Australian Patent in National Phase
http://pericles.ipaustralia.gov.au/ols/auspat/applicationDetails.do?applicationNo=2011352928


Canadian Patent in National Phase
http://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/2823123/summary.html

IntelliCell Biosciences Announces it Has Received Notification That International Patents for Canada, Europe and Korea Are Filed and Pending Approvals
https://finance.yahoo.com/news/intellicell-biosciences-announces-received-notification-180000807.html

IntelliCell BioSciences Receives Notice of Its Thailand Patent Application for Its Stem Cell Extraction
Technology
http://finance.yahoo.com/news/intellicell-biosciences-receives-notice-thailand-141500163.html
http://203.209.117.243/DIPSearch/PatentSearch/DipData.aspx?apptype=th&Appno=11317700245

[cazual]

SVFC $$$$ Very exciting developments underway! Recently In Seoul #Korea at #stemcell center teaching our treatments to #Chaum from #RegenMedicalPC and #Intellicell pic.twitter.com/yBqtKNDi48

Treating patients successfully with the SVFC Patented Stem Cell Technology at Chaum Global Stem Cell Clinical Trials Center...improving the quality of life for people...clinical trials...partnerships...revenues...International Patent..Globalization of SVFC Tech! Exciting future for SVFC $$$$

https://twitter.com/stevenvictormd
http://ctc.chastemcell.com/en/People/Sub01.aspx
https://finance.yahoo.com/news/intellicell-biosciences-announces-received-notification-180000807.html

GO SVFC $$$$

[cazual]

“We are especially pleased to be partnering with ReGen Medical,” states Repair Stem Cell Institute Founder and Chairman Don Margolis, “because of their impeccable record with clinical trials in the application of stem cell treatment to osteoarthritis, gingival gum regeneration, sports medicine injuries, and dermal treatments for burns and non-healing wounds.”


Dr. Victor created a patented process, which yields millions of Stromal Vascular Fraction Cells, largely comprised of autologous (the patient’s own) adult stem cells. This patented technology is owned by IntelliCell BioSciences, of which Dr. Victor is the founder and CEO, and licensed by ReGen Medical to utilize for the treatment of patients. Because the use of autologous adult stem cells means that the donor and recipient is the same person, risk of rejection or adverse reactions is all but eliminated.

Dallas, TX -- (SBWIRE) -- 02/05/2014 -- The Repair Stem Cell Institute (RSCI) – http://www.repairstemcells.org -- is pleased to announce its business alliance with ReGen Medical, PC (http://www.regenmedicalpc.com) of New York City, making it one of the 14 international stem cell treatment center RSCI represents.

http://www.sbwire.com/press-releases/the-repair-stem-cell-institute-announces-its-alliance-with-regen-medical-pc-a-leader-in-regenerative-medicine-453471.htm

GO SVFC $$$$

[Gannicus]

* SVFC - One or more of these three can hit at any day now:


1) European Patent Granted (The company knows before the website is updated)


2) The PR about the CEO's trip to South Korea's Global Stem Cell Center

Here is why it would make business sense for Koreans to partner with Intellicell:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=95147594


3) The PR about the potential partnership or financing (PRE-14C events + "Eilon rocks paperwork")

Read the two possibilities in the following two links:

Theory 1: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=96376346

Theory 2: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=96438728

[phattrader]

I thought the management here was misappropriating funds illegally to regen and you and your corporate attorneys were going to intervene with the judge in the ironridge case with your dossiers etc...how did that work out for ya?

so now your back on board?

LMAO